 |
|
Reviews & Comments
ABSA Comments on the Select Agent Program & Biosecurities Improvement Act(PDF 32KB); March 28, 2008
ABSA Position Paper on Accreditation of High Containment Laboratories(PDF 24KB); April 18, 2008
ABSA Comments on the Proposed Framework for the Oversight of Dual Use(PDF 92KB); Nov. 19, 2007
ABSA Comments Regarding the 5th Edition of the Biosafety in Microbiological and Biomedical Laboratories (BMBL). (PDF 108KB)
a letter written by Bill Homovec, MPH, CBSP, Chair and Co Team Leader, ABSA Technical and Regulatory Review Committee, May 2, 2007
ABSA Comments Regarding the Draft Pandemic Influenza Preparedness and Response Plan
a letter written by Elizabeth Gilman Duane, MS, RBP, CBSP, President, ABSA,
October 25, 2004
ABSA Comments Regarding Operational Issues of the CDC Select Agent Program
a letter written by Stefan Wagener, Ph.D., RBP, CBSP, President, ABSA,
6 April 2004
CDC Response to ABSA Comments Regarding the CDC Select Agent Program
ABSA Comments Regarding National Committee of Clinical Laboratory
Standard, NM29-3A, Protection of Laboratory Workers from
Occupationally-Acquired Infections
a letter written by Stefan Wagener, Ph.D., RBP, CBSP, President, ABSA, 5
April 2004
ABSA Comments on CDC Select Agent Rule
a letter written by Barbara Johnson, Ph.D., RBP, President, ABSA,
5 February 2003
Letter from the Biosecurity Task Force(PDF 496KB)
a letter written by Barbara Johnson, Ph.D., RBP, President-Elect, ABSA, and the ABSA Biosecurity Task Force, June 2002
ABSA Comments on Health Canada Revisions, American Biological Safety Association
a letter written by Debra Hunt, DrPh, RBP, CBSP,
Past-President, ABSA,
4 March 2002
CDC - "Draft Guideline for Hand Hygiene in Healthcare Settings"
a letter written by Maureen Best,
President, American Biological Safety Association,
7 December 2001
NIH Guidelines for Research Involving Recombinant DNA Molecules
a letter written by Debra Hunt, DrPH, RBP, CBSP (ABSA),
President, American Biological Safety Association,
10 September 2001
NCCLS - Protection of Laboratory Workers from Occupationally-Acquired Infections
a letter written by Debra Hunt, MT (ASCP), DrPH, CBSP (ABSA),
President, American Biological Safety Association,
29 August 2001
Response to: Hazardous Materials: Revision to Standards for Infectious Substances and Genetically Modified Microorganisms
a letter written by Debra Hunt, Dr.PH, RBP, CBSP (ABSA),
President, American Biological Safety Association,
18 April 2001
HIV Prevention Plan Comments
a letter written by Debra Hunt, Dr.PH, RBP, CBSP,
President, American Biological Safety Association,
5 February 2001
ABSA Response To: NIH Guidelines for Research Involving Recombinant DNA Molecules
a letter written by Debra Hunt, Dr.PH, RBP, CBSP (ABSA),
President, American Biological Safety Association,
February 2001
Arthropod Containment Guidelines (ACG)
a letter written by Debra L. Hunt, Dr.PH , RBP, CBSP (ABSA),
President, American Biological Safety Association,
February 2001
ABSA's Response to the "Needlestick Safety Prevention Act"
a letter written by John H. Keene, Dr.PH, CBSP (ABSA),
President, American Biological Safety Association,
17 October 2000
Institute of Medicine Response - Response to the OSHA TB Standard
a letter written by John H. Keene, Dr.PH, CBSP (ABSA) President,
American Biological Safety Association,
29 July 2000
ABSA comments on: 42 CFR Part 72 "Packaging and Handling of Infectious Substances and Select Agents" (CDC NPRM, 1999)
a letter written by John H. Keene, Dr.PH, CBSP (ABSA),
President, American Biological Safety Association,
21 December 1999
|
|
|
